NATA - Nucleic Acid Therapy Accelerator
@natahub.org
Advancing the development of nucleic acid therapies and associated technologies through high-quality science, collaborations and interdisciplinary research
We’re excited to launch our new quarterly newsletter — aim to give you a closer look at the work we’re doing at NATA.
📩 Sign up here to receive future editions: mailchi.mp/natahub.org/...
📖 Read the latest edition: mailchi.mp/natahub.org/...
#NATA #Newsletter #HealthcareInnovation #ScienceUpdate
📩 Sign up here to receive future editions: mailchi.mp/natahub.org/...
📖 Read the latest edition: mailchi.mp/natahub.org/...
#NATA #Newsletter #HealthcareInnovation #ScienceUpdate
May 13, 2025 at 9:41 AM
We’re excited to launch our new quarterly newsletter — aim to give you a closer look at the work we’re doing at NATA.
📩 Sign up here to receive future editions: mailchi.mp/natahub.org/...
📖 Read the latest edition: mailchi.mp/natahub.org/...
#NATA #Newsletter #HealthcareInnovation #ScienceUpdate
📩 Sign up here to receive future editions: mailchi.mp/natahub.org/...
📖 Read the latest edition: mailchi.mp/natahub.org/...
#NATA #Newsletter #HealthcareInnovation #ScienceUpdate
🎉NATA’s work is featured in Nucleic Acid Therapeutics!
A new article, led by Rockland Immunochemicals, includes images from Inês Fial. The journal cover also features her images; re-designed by Peter Oliver!
Congratulations to our Biology team!
🔗Read the paper: www.liebertpub.com/doi/10.1089/...
A new article, led by Rockland Immunochemicals, includes images from Inês Fial. The journal cover also features her images; re-designed by Peter Oliver!
Congratulations to our Biology team!
🔗Read the paper: www.liebertpub.com/doi/10.1089/...
March 13, 2025 at 1:27 PM
🎉NATA’s work is featured in Nucleic Acid Therapeutics!
A new article, led by Rockland Immunochemicals, includes images from Inês Fial. The journal cover also features her images; re-designed by Peter Oliver!
Congratulations to our Biology team!
🔗Read the paper: www.liebertpub.com/doi/10.1089/...
A new article, led by Rockland Immunochemicals, includes images from Inês Fial. The journal cover also features her images; re-designed by Peter Oliver!
Congratulations to our Biology team!
🔗Read the paper: www.liebertpub.com/doi/10.1089/...
🌍Today is Rare Disease Day!
Here’s a reminder that with over 300 million people worldwide living with a rare disease—only 5% having approved treatments—there is still so much work to be done.
At NATA, we are committed to advancing nucleic acid therapies for rare diseases.
#RareDiseaseDay
Here’s a reminder that with over 300 million people worldwide living with a rare disease—only 5% having approved treatments—there is still so much work to be done.
At NATA, we are committed to advancing nucleic acid therapies for rare diseases.
#RareDiseaseDay
February 28, 2025 at 1:21 PM
🌍Today is Rare Disease Day!
Here’s a reminder that with over 300 million people worldwide living with a rare disease—only 5% having approved treatments—there is still so much work to be done.
At NATA, we are committed to advancing nucleic acid therapies for rare diseases.
#RareDiseaseDay
Here’s a reminder that with over 300 million people worldwide living with a rare disease—only 5% having approved treatments—there is still so much work to be done.
At NATA, we are committed to advancing nucleic acid therapies for rare diseases.
#RareDiseaseDay